Literature DB >> 5685511

Seromucoids and serum lipids: an epidemiological study of an active Montreal population.

C Allard, C Goulet.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5685511      PMCID: PMC1945301     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  9 in total

Review 1.  GLYCOPROTEINS: STRUCTURE, METABOLISM AND BIOLOGY.

Authors:  R G SPIRO
Journal:  N Engl J Med       Date:  1963-09-19       Impact factor: 91.245

2.  Serum glycoproteins in the rheumatic diseases.

Authors:  R W PAYNE
Journal:  Ann N Y Acad Sci       Date:  1961-08-31       Impact factor: 5.691

3.  Effect of atherosclerosis and age upon the serum mucoprotein and hexosamine levels in man.

Authors:  C J SCHWARTZ; H R GILMORE
Journal:  Circulation       Date:  1958-08       Impact factor: 29.690

4.  Serum glyco protein concentrations in experimental tuberculosis of guinea pigs.

Authors:  H E WEIMER; J R MOSHIN
Journal:  Am Rev Tuberc       Date:  1953-10

5.  Commentaries.

Authors:  C Allard
Journal:  Can Med Assoc J       Date:  1967-03-25       Impact factor: 8.262

6.  Correlation of serum lipid pattern with the concentration of mucopolysaccharides in normal and hyperlipemic human sera.

Authors:  M Végh; M Bihari-Varga
Journal:  Clin Chim Acta       Date:  1967-06       Impact factor: 3.786

7.  Seromucoid patterns of normal and tuberculous individuals as determined by a disc electrophoresis technique.

Authors:  W H Price; H Harrison; J Molenda
Journal:  Am J Epidemiol       Date:  1966-01       Impact factor: 4.897

8.  Qualitative and quantitative alterations in serum serumucoid in malignant neoplastic disease.

Authors:  H Bacchus; E R Kennedy; J Balckwell
Journal:  Cancer       Date:  1967-10       Impact factor: 6.860

9.  Effects of oxyphenbutazone (tandearil) on plasma seromucoids. II. In postoperative inflammation.

Authors:  R BARCELO; C LEBLANC; P RIOPEL; L P LEGRESLEY
Journal:  Can Med Assoc J       Date:  1963-03-23       Impact factor: 8.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.